Organon (OGN) Accumulated Expenses (2020 - 2026)

Organon (OGN) has reported Accumulated Expenses for 7 consecutive years, with $1.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses rose 0.78% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 0.78% YoY), while the FY2025 annual figure was $1.3 billion, down 5.39% from the prior year.
• Accumulated Expenses came in at $1.4 billion for Q1 2026 at Organon, up from $1.3 billion in the prior quarter.
• The five-year high for Accumulated Expenses was $1.5 billion in Q3 2024, with the low at $1.0 billion in Q1 2022.
• Average Accumulated Expenses over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2025.
• Across the five-year window, Accumulated Expenses jumped 33.6% in 2022 and fell 5.39% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $1.2 billion in 2022, then rose by 16.92% to $1.4 billion in 2023, then rose by 1.58% to $1.4 billion in 2024, then slipped by 5.39% to $1.3 billion in 2025, then rose by 6.67% to $1.4 billion in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $1.4 billion, $1.3 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.